Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
Bone metastases
First Phase III trial of an alpha-pharmaceutical
First Phase III trial of an alpha-pharmaceutical
eurekalert.org
Algeta
Alpharadin
Bayer
Bone metastases
prostate cancer
Exelixis: Still Promising, Still Controversial
Exelixis: Still Promising, Still Controversial
Seeking Alpha
Bone metastases
cabozantinib
Exelixis
News
Amgen's Hopes for Prolia Go Beyond Osteoporosis Therapy
Seeking Alpha
Amgen
Bone metastases
osteoporosis
Prolia
»
2 comments
News
Amgen Highlights Key Clinical Data to Be Presented at American Society of Clinical Oncology Annual Meeting
PR-USA
Amgen
Bone metastases
denosumab
prostate cancer
zoledronic acid
»
Login
or
register
to post comments
News
Amgen Submits Denosumab Biologics License Application to FDA for the Reduction of Skeletal Related Events in Cancer Patients
Amgen, PR NewsWire
Amgen
Bone metastases
denosumab
»
2 comments
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT